No abstract available
MeSH terms
-
Abnormalities, Multiple / drug therapy*
-
Abnormalities, Multiple / genetics
-
Abnormalities, Multiple / surgery
-
Adolescent
-
Cardiomyopathy, Dilated / drug therapy*
-
Cardiomyopathy, Dilated / genetics
-
Cardiomyopathy, Dilated / surgery
-
Cardiotonic Agents / therapeutic use*
-
Cell Cycle Proteins
-
Heart-Lung Transplantation*
-
Humans
-
Hydrazones / therapeutic use*
-
Hypertension, Pulmonary / drug therapy*
-
Hypertension, Pulmonary / genetics
-
Hypertension, Pulmonary / surgery
-
Male
-
Proteins
-
Pyridazines / therapeutic use*
-
Simendan
-
Syndrome
-
Treatment Outcome
-
Waiting Lists*
Substances
-
ALMS1 protein, human
-
Cardiotonic Agents
-
Cell Cycle Proteins
-
Hydrazones
-
Proteins
-
Pyridazines
-
Simendan